North Shore - Long Island Jewish Health System is a clinical research site located in New Hyde Park, New York, United States 11040.
Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.
North Shore - Long Island Jewish Health System has participated in 3 clinical trials.
Therapeutic areas: Lymphoma, Follicular, Lymphoma, Mixed-Cell, Follicular, Lymphoma, Small Cleaved-Cell, Follicular.
Sponsors: CTI BioPharma, American Lung Association Asthma Clinical Research Centers, United Therapeutics.
Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
North Shore - Long Island Jewish Health System has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
North Shore - Long Island Jewish Health System has 3 clinical trials on record. Their work covers Lymphoma, Follicular, Lymphoma, Mixed-Cell, Follicular, Lymphoma, Small Cleaved-Cell, Follicular.
North Shore - Long Island Jewish Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.